Transparency Market Research Reports included a detailed market survey and analysis trends on “Chronic Kidney Disease Market”. This report also includes more info about basic overview of the industry including definitions, applications and global market industry structure.Chronic
kidney disease (CKD), which is also known as chronic renal disease, is caused
due to progressive loss of proper functioning of the kidneys and associated
renal system over a longer period of time either months or years. Chronic
kidney diseases often go unnoticed, as the individuals suffering from the
disease are seen to be having non-specific symptoms like feeling unwell, or
loss of appetite among others. Many a times, patients suffering from a chronic
kidney disorder are diagnosed due to their screening for diabetes, high blood
pressure and others.
Browse
Full Report with TOC: http://www.transparencymarketresearch.com/chronic-kidney-disease.html
However,
patients suffering from this chronic disease also suffer from other disorders
and show symptoms of diseases, such as, cardiovascular disease, pericarditis,
and anemia. A chronic kidney disease has been classified into five major stages
of the severity of the disease, where the first stage represents mildest
disease condition and the fifth stage with most severe conditions that may lead
to death. CKD market is bound to experience high growth in the near future as
most of the big pharmaceutical companies are doing extensive research on
developing new and specific drugs for the disease. Disease diagnostic tests as
well as test kits and others will also grow with the growing demand from this
CKD market.
Major
driving factors for the growth of this market include, increasing incidences
and prevalence of chronic kidney disease worldwide, rising demand for advanced
diagnostics and therapeutics for the disease, aging population and increasing
number of individuals suffering from diabetes, high blood pressure etc.
Increasing number of people suffering from disorders like diabetes, high blood
pressure, and others are also contributing towards the increasing incidence
rate and prevalence of CKD worldwide. According to CDC, U.S. more than 26
million people in the U.S. were suffering from CKD in 2006 and around 45,000
people died of it in the same year. It was also estimated that around 44% of
the patients suffering from CKD are due to their diabetes condition and around
28% of them had the disease due to their high blood pressure.
Thus,
the increasing prevalence of the disease will continue to demand more form this
market, hence will contribute towards the growth of this market in future. But,
patent expiries of some of the major branded drugs for late stage CKD and
changing reimbursement scenario in some of the major markets like the U.S.,
U.K. and others may restrain the growth of this market. However, increasing
awareness and affordability of the people across geographies along with the
launch of some of the pipelined drugs in the coming future will provide boost
to the growth of this market in future.
Geographically,
North America holds the leading position in the global CKD market followed by
the European market. Major factors responsible for the growth of this market in
the region are high prevalence of the disease especially in the U.S.,
well-established healthcare infrastructure, and high affordability and
awareness levels of the people of these regions. Asia-Pacific region is
expected to show high growth in the near future due to increasing number of
diabetic and high blood pressure patients that ultimately lead to CKD, rising
healthcare awareness in the region and increasing demand for advanced
diagnostics and therapeutics for CKD in the region.
Some
of the major players operating in the CKD market are Acceleron Pharma, Inc.,
Amgen, Inc., AstraZeneca plc, Eli Lilly and Company, Evotec AG, OPKO Health,
Inc., Quark Pharmaceuticals, Inc., Nippon Zoki Pharmaceutical Co., Ltd., Panion
& Bf Biotech, Inc., Vifor Pharma AG, and Sanofi.
This research report
analyzes this market depending on its market segments, major geographies, and
current market trends. Geographies analyzed under this research report
include
- North America
- Asia Pacific
- Europe
- Rest of the World
This report provides comprehensive
analysis of
- Market
growth drivers
- Factors
limiting market growth
- Current
market trends
- Market
structure
- Market
projections for upcoming years
More
Reports on Medical Devices Market: http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html
About Us:-
Transparency
Market Research (TMR) is a market intelligence company providing global
business research reports and consulting services. Our exclusive blend of
quantitative forecasting and trends analysis provides forward-looking insights
for thousands of decision-makers.
Contact Us
Sheela AK
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
Tel: +1-518-618-1030
Browse
Market Research Report:-
%2BMarket.png)
